Lyell Immunopharma Statistics
Total Valuation
LYEL has a market cap or net worth of $369.83 million. The enterprise value is $94.49 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYEL has 21.22 million shares outstanding. The number of shares has increased by 21.43% in one year.
| Current Share Class | 21.22M |
| Shares Outstanding | 21.22M |
| Shares Change (YoY) | +21.43% |
| Shares Change (QoQ) | +23.49% |
| Owned by Insiders (%) | 2.37% |
| Owned by Institutions (%) | 33.54% |
| Float | 12.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9,020.33 |
| Forward PS | n/a |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,304.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.30, with a Debt / Equity ratio of 0.13.
| Current Ratio | 10.30 |
| Quick Ratio | 10.03 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -75.75% and return on invested capital (ROIC) is -25.78%.
| Return on Equity (ROE) | -75.75% |
| Return on Assets (ROA) | -24.16% |
| Return on Invested Capital (ROIC) | -25.78% |
| Return on Capital Employed (ROCE) | -52.79% |
| Revenue Per Employee | $137 |
| Profits Per Employee | -$1.09M |
| Employee Count | 300 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.49% in the last 52 weeks. The beta is -0.07, so LYEL's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | -21.49% |
| 50-Day Moving Average | 16.22 |
| 200-Day Moving Average | 11.94 |
| Relative Strength Index (RSI) | 53.60 |
| Average Volume (20 Days) | 23,902 |
Short Selling Information
The latest short interest is 166,193, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 166,193 |
| Short Previous Month | 183,877 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 1.37% |
| Short Ratio (days to cover) | 5.12 |
Income Statement
In the last 12 months, LYEL had revenue of $41,000 and -$325.66 million in losses. Loss per share was -$21.06.
| Revenue | 41,000 |
| Gross Profit | 41,000 |
| Operating Income | -198.55M |
| Pretax Income | -325.66M |
| Net Income | -325.66M |
| EBITDA | -184.38M |
| EBIT | -198.55M |
| Loss Per Share | -$21.06 |
Full Income StatementBalance Sheet
The company has $319.62 million in cash and $44.29 million in debt, giving a net cash position of $275.34 million or $12.98 per share.
| Cash & Cash Equivalents | 319.62M |
| Total Debt | 44.29M |
| Net Cash | 275.34M |
| Net Cash Per Share | $12.98 |
| Equity (Book Value) | 329.12M |
| Book Value Per Share | 17.06 |
| Working Capital | 296.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$165.02 million and capital expenditures -$520,000, giving a free cash flow of -$165.54 million.
| Operating Cash Flow | -165.02M |
| Capital Expenditures | -520,000 |
| Free Cash Flow | -165.54M |
| FCF Per Share | -$7.80 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -484,265.85% |
| Pretax Margin | -794,292.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.43% |
| Shareholder Yield | -21.43% |
| Earnings Yield | -88.06% |
| FCF Yield | -44.76% |
Analyst Forecast
The average price target for LYEL is $15.00, which is -13.94% lower than the current price. The consensus rating is "Buy".
| Price Target | $15.00 |
| Price Target Difference | -13.94% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 342.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
LYEL has an Altman Z-Score of -4.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.32 |
| Piotroski F-Score | 1 |
